BioLife Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,100	1,204	732	778	1,552	1,306
Market Cap Growth	-13.18%	64.50%	-5.95%	-49.85%	18.87%	294.61%
Enterprise Value	1,022	1,204	735	761	1,505	1,213
Last Close Price	22.84	25.96	16.25	18.20	37.27	39.89
PE Ratio	-	-	-	-	-	716.70
Forward PE	175.25	-	-	-	-	-
PS Ratio	10.98	14.64	9.65	10.21	13.03	27.16
PB Ratio	3.10	3.45	2.17	2.14	3.25	6.36
P/TBV Ratio	8.21	9.48	6.46	7.25	15.34	11.28
P/FCF Ratio	109.56	384.00	-	-	-	-
P/OCF Ratio	65.29	142.83	-	-	-	196.51
EV/Sales Ratio	10.21	14.64	9.69	9.98	12.63	25.22
EV/EBITDA Ratio	-	-	-	-	-	818.78
EV/FCF Ratio	101.82	384.06	-	-	-	-
Debt / Equity Ratio	0.06	0.09	0.10	0.12	0.06	0.05
Debt / EBITDA Ratio	11.44	19.84	-	-	-	3.78
Debt / FCF Ratio	2.06	9.62	-	-	-	-
Net Debt / Equity Ratio	-0.22	-0.23	-0.03	-0.05	-0.09	-0.39
Net Debt / EBITDA Ratio	40.84	48.25	0.59	6.13	2.58	-53.51
Net Debt / FCF Ratio	-7.74	-25.20	0.46	0.85	2.22	68.14
Asset Turnover	0.26	0.20	0.18	0.15	0.30	0.29
Inventory Turnover	1.19	1.02	0.96	0.93	4.05	1.79
Quick Ratio	3.31	3.48	1.24	2.17	2.18	6.32
Current Ratio	4.66	4.55	2.86	3.11	2.95	7.37
Return on Equity (ROE)	-5.25%	-3.32%	-5.26%	0.09%	-2.61%	1.59%
Return on Assets (ROA)	-0.73%	-1.10%	-3.71%	-1.33%	-4.68%	-1.37%
Return on Capital Employed (ROCE)	-1.20%	-1.90%	-6.90%	-2.60%	-5.80%	-1.60%
Earnings Yield	-0.29%	-1.68%	-9.29%	-17.96%	-0.57%	0.15%
FCF Yield	0.91%	0.26%	-3.24%	-2.88%	-1.25%	-0.09%
Buyback Yield / Dilution	-3.88%	-5.37%	-1.50%	-11.87%	-41.01%	-40.32%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q